HIGHLIGHTS
- who: Laura Feeney and colleagues from the Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester , BX, UKDepartment of Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol , NU, UK have published the Article: Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma, in the Journal: (JOURNAL) of 24/06/2021
- what: The aim of this study was to determine radiological response rates, by RECIST criteria, with multikinase inhibition using lenvatinib monotherapy in R/M ACC to compare the real-world outcomes with the prior results of clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.